Xencor (Monrovia, CA) has appointed Jeffrey D. Bloss, MD, chief medical officer. Bloss will direct Xencor's clinical and preclinical development strategies.
Xencor (Monrovia, CA) has appointed Jeffrey D. Bloss, MD, chief medical officer. Bloss will direct Xencor's clinical and preclinical development strategies. He will be responsible for building the company's clinical development team and for the design and implementation of studies to evaluate the company's pipeline of novel antibody and protein therapeutics. Most recently, Bloss was the vice president of clinical development at Onyx Pharmaceuticals, Inc., where he led the development for sorafenib.
